|
42
|
125
|
5hq6A |
Crystal structure of fragment bound with brd4 |
|
51
|
180
|
5h1uA |
Complex structure of trim24 phd-bromodomain and inhibitor 2 |
|
42
|
127
|
5hlsA |
Crystal structure of the first bromodomain of human brd4 bound to cpi-0610 |
|
48
|
127
|
5hclA |
Crystal structure of the first bromodomain of brd4 in complex with dma |
|
44
|
125
|
5hm0A |
Crystal structure of the first bromodomain of human brd4 bound to benzoisoxazoloazepine 3 |
|
50
|
182
|
5h1tA |
Complex structure of trim24 phd-bromodomain and inhibitor 1 |
|
42
|
109
|
5fe7A |
Crystal structure of human pcaf bromodomain in complex with fragment zb2216 (fragment 11) |
|
42
|
118
|
5fg6A |
Crystal structure of the bromodomain of human brd1 (brpf2) in complex with of-1 chemical probe |
|
39
|
108
|
5fe8A |
Crystal structure of human pcaf bromodomain in complex with compound sl1126 (compound 12) |
|
40
|
108
|
5fe5A |
Crystal structure of human pcaf bromodomain in complex with fragment mb093 (fragment 7) |
|
41
|
109
|
5fe9A |
Crystal structure of human pcaf bromodomain in complex with compound sl1122 (compound 13) |
|
39
|
107
|
5fe2A |
Crystal structure of human pcaf bromodomain in complex with fragment br013 (fragment 3) |
|
41
|
127
|
5ad2A |
Bivalent binding to bet bromodomains |
|
44
|
127
|
5acyA |
N-terminal bromodomain of human brd4 with 1-(2r,4s)-2-methyl-4-(phenylamino)-6-4-(piperidin-1-ylmethyl)phenyl-1,2,3,4- tetrahydroquinolin-1-yl-ethan-1-one |
|
40
|
115
|
4curA |
Crystal structure of human baz2b in complex with fragment-3 n09555 |
|
43
|
127
|
4cl9A |
N-terminal bromodomain of human brd4 with i-bet295 |
|
41
|
129
|
5d0cA |
Crystal structure of the first bromodomain of human brd4 in complex with benzo[cd]indol-2(1h)-one ligand |
|
38
|
113
|
5c89A |
Crystal structure of the human brpf1 bromodomain in complex with 917 |
|
43
|
131
|
5cy9A |
Crystal structure of the first bromodomain of human brd4 in complex with benzo[cd]indol-2(1h)-one ligand |
|
44
|
122
|
5c8gA |
Crystal structure analysis of pp-brd20 from tb427tmp complexed with bi-2536 |
|
41
|
132
|
5coiA |
Crystal structure of the first bromodomain of human brd4 in complex with benzo[cd]indol-2(1h)-one ligand |
|
38
|
108
|
5fe0A |
Crystal structure of human pcaf bromodomain in complex with acetyllysine |
|
42
|
113
|
5f1lA |
Crystal structure of the bromodomain of brd9 in complex with compound 9. |
|
39
|
112
|
5c7nA |
Crystal structure of the human brpf1 bromodomain in complex with bromosporine |
|
41
|
112
|
5c87A |
Crystal structure of the human brpf1 bromodomain in complex with seed2 |
|
33
|
118
|
5c4qA |
Crystal structure analysis of bromodomain from leishmania donovani complexed with bromosporine |
|
41
|
112
|
5c85A |
Crystal structure of the human brpf1 bromodomain in complex with seed1 |
|
43
|
114
|
5bt3A |
Crystal structure of ep300 bromodomain in complex with sgc-cbp30 chemical probe |
|
43
|
110
|
5bt5A |
Crystal structure of brd2 second bromodomain in complex with sgc-cbp30 chemical probe |
|
42
|
127
|
5bt4A |
Crystal structure of brd4 first bromodomain in complex with sgc-cbp30 chemical probe |
|
45
|
121
|
5amfA |
Crystal structure of the bromodomain of human surface epitope engineered brd1a in complex with 3d consortium fragment ethyl 4,5,6,7- tetrahydro-1h-indazole-5-carboxylate (sgc - diamond i04-1 fragment screening) |
|
41
|
112
|
5a7cA |
Crystal structure of the second bromodomain of human brd3 in complex with compound |
|
55
|
130
|
5a5rA |
Crystal structure of human atad2 bromodomain in complex with 5-5- methoxypyridin-3-yl-3-methyl-8-piperidin-4-ylamino-1,2-dihydro-1,7- naphthyridin-2-one |
|
40
|
127
|
5ad3A |
Bivalent binding to bet bromodomains |
|
52
|
130
|
5a5pA |
Crystal structure of human atad2 bromodomain in complex with 8-2-(dimethylamino)ethylamino-3-methyl-1,2-dihydroquinolin-2-one |
|
54
|
130
|
5a82A |
Crystal structure of human atad2 bromodomain in complex with 4-(3r,4r) -4-(3-methyl-2-oxo-1,2-dihydro-1,7-naphthyridin-8-yl)aminopiperidin-3- yloxymethyl)-1-thiane-1,1-dione |
|
55
|
130
|
5a5qA |
Crystal structure of human atad2 bromodomain in complex with 3-methyl- 8-piperidin-4-ylamino-1,2-dihydro-1,7-naphthyridin-2-one hydrochloride |
|
44
|
127
|
5a5sA |
Nn-terminal bromodomain of human brd4 with 5-5-methoxypyridin-3-yl-3- methyl-8-piperidin-4-ylamino-1,2-dihydro-1,7-naphthyridin-2-one |
|
54
|
130
|
5a5oA |
Crystal structure of human atad2 bromodomain in complex with 3-methyl- 1,2-dihydroquinolin-2-one |
|
37
|
101
|
4yyjA |
Crystal structure of brd9 bromodomain bound to a butyryllysine peptide |
|
50
|
132
|
4yymA |
Crystal structure of taf1 bd2 bromodomain bound to a butyryllysine peptide |
|
52
|
183
|
4ybmA |
Crystal structure of trim24 phd-bromodomain complexed with n-{6-[3-(benzyloxy)phenoxy]-1,3-dimethyl-2-oxo-2,3-dihydro-1h-1,3-benzodiazol-5-yl}-3,4-dimethoxybenzene-1-sulfonamide (7b) |
|
43
|
124
|
4z1qA |
Crystal structure of the first bromodomain of human brd4 bound to benzotriazolo-diazepine scaffold |
|
37
|
101
|
4yykA |
Crystal structure of brd9 bromodomain bound to a crotonyllysine peptide |
|
44
|
113
|
4z6iA |
Crystal structure of brd9 bromodomain in complex with a substituted valerolactam quinolone ligand |
|
57
|
183
|
4ybsA |
Crystal structure of trim24 phd-bromodomain complexed with n-{1,3-dimethyl-6-[3-(2-methylpropoxy)phenoxy]-2-oxo-2,3-dihydro-1h-1,3-benzodiazol-5-yl}-1,2-dimethyl-1h-imidazole-4-sulfonamide (7g) |
|
35
|
101
|
4yydA |
Crystal structure of brd9 bromodomain bound to a crotonyllysine peptide |
|
42
|
126
|
4z1sA |
Crystal structure of the first bromodomain of human brd4 with benzotriazolo-diazepine scaffold |
|
35
|
100
|
4yyiA |
Crystal structure of brd9 bromodomain bound to an acetylated peptide |
|
36
|
101
|
4yy4A |
Crystal structure of brd9 bromodomain bound to dmso |
